Pitavastatin Inhibits Intimal Hyperplasia in Rabbit Vein Graft

Journal of Surgical Research

Volumn 148, Issue 2, 2008, Pages 238-243

  Fujita, Hiromine ^a   Banno, Hiroshi ^a   Yamanouchi, Dai ^a   Kobayashi, Masayoshi ^a   Yamamoto, Kiyohito ^a   Komori, Kimihiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors; Midkine; Neointima formation; Pitavastatin; Vein graft

Indexed keywords

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; MIDKINE; PITAVASTATIN;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOGRAFT; CAROTID ARTERY; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; JUGULAR VEIN; LEG; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SAPHENOUS VEIN; VEIN GRAFT; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; CORONARY ARTERY BYPASS; CYTOKINES; ENZYME INHIBITORS; HYPERPLASIA; JUGULAR VEINS; LIPIDS; MALE; QUINOLINES; RABBITS; TUNICA INTIMA;

EID: 46249117286     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.08.017     Document Type: Article

References (29)

1. Watson H.R., Buth J., Schroeder T.V., et al. Incidence of stenoses in femorodistal bypass vein grafts in a multicenter study. Eur J Vasc Endovasc Surg 20 (2000) 67
2. Belkin M., Knox J., Donaldson M.C., et al. Infrainguinal arterial reconstruction with nonreversed greater saphenous vein. J Vasc Surg 24 (1996) 957
3. Veith F.J., Gupta S.K., Ascer E., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104
4. Christenson J.T. Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. Am J Cardiol 88 (2001) 896
5. Henke P.K., Blackburn S., Proctor M.C., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004) 357
6. Abbruzzese T.A., Havens J., Belkin M., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004) 1178
7. Hayashi K., Banno H., Kadomatsu K., et al. Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury. Am J Physiol Heart Circ Physiol 288 (2005) H2203
8. Soma M.R., Donetti E., Parolini C., et al. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb 13 (1993) 571
9. Bandoh T., Mitani H., Niihashi M., et al. Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery. Eur J Pharmacol 315 (1996) 37
10. Yamanouchi D., Banno H., Nakayama M., et al. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. J Vasc Surg 42 (2005) 757
11. Saito Y., Yamada N., Teramoto T., et al. Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison. Arzneimittelforschung 52 (2002) 251
12. Kitahara M., Kanaki T., Toyoda K., et al. NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery. Jpn J Pharmacol 77 (1998) 117
13. Sato W., Takei Y., Yuzawa Y., et al. Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Kidney Int 67 (2005) 1330
14. Gueler F., Rong S., Park J.K., et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13 (2002) 2288
15. Williams D., and Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 41 (2002) 343
16. U.S. Department of Health, Education, and Welfare. Lipid Research Program/Vol. I, 2nd ed.: Lipid and Lipoprotein Analysis. Publ. No. (NIH) 76-628. Washington, DC: U.S. Govt. Printing Office, 1982.
17. Ohta S., Komori K., Yonemitsu Y., et al. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: A limited biological effect as a result of the loss of medial smooth muscle cells. Surgery 131 (2002) 644
18. Ishida M., Komori K., Yonemitsu Y., et al. Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling. Atherosclerosis 154 (2001) 345
19. Kadomatsu K., Hagihara M., Akhter S., et al. Midkine induces the transformation of NIH3T3 cells. Br J Cancer 75 (1997) 354
20. Itoh H., Komori K., Funahashi S., et al. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis 110 (1994) 259
21. Komori K., Gloviczki P., Bourchier R.G., et al. Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts. J Vasc Surg 12 (1990) 139
22. Komori K., Inoguchi H., Kume M., et al. Differences in endothelial function and morphologic modulation between canine autogenous venous and arterial grafts: Endothelium and intimal thickening. Surgery 131 (2002) S249
23. Ohta S., Komori K., Yonemitsu Y., et al. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: A limited biological effect as a result of the loss of medial smooth muscle cells. Surgery 131 (2002) 644
24. Itoh H., Komori K., Okazaki J., et al. The effect of probucol on intimal thickening of autologous vein grafts in hyperlipidemic rabbit. Cardiovasc Surg 5 (1997) 497
25. Kadomatsu K., Tomomura M., and Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151 (1988) 1312
26. Kadomatsu K., and Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204 (2004) 127
27. Maruyama K., Muramatsu H., Ishiguro N., et al. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50 (2004) 1420
28. Banno H., Takei Y., Muramatsu T., et al. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 44 (2006) 633
29. Bellosta S., Bernini F., Ferri N., et al. Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis 137 (1998) S101